Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
Abstract Objective We aim to describe and highlight the current use of immune checkpoint inhibitors (ICIs) in the muscle invasive bladder cancer (MIBC) treatment landscape, particularly focusing on the perioperative setting. We provide a comprehensive review of key trials of the use of ICI in the pe...
Main Authors: | Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-01-01
|
Series: | Oncology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40487-022-00218-z |
Similar Items
-
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
by: Biagio Barone, et al.
Published: (2022-05-01) -
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
by: Jorge Esteban-Villarrubia, et al.
Published: (2023-01-01) -
High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01) -
High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01) -
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)